Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics

Biophysical Journal

Volumn 87, Issue 6, 2004, Pages 4087-4097

  Chillemi, G ^a   Redinbo, M ^b   Bruselles, A ^a,c   Desideri, A ^c  

^a CASPUR   (Italy)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CRYSTALLOGRAPHY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME STABILITY; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS;

EID: 10044289709     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.044925     Document Type: Article

References (56)

1. Andoh, T., K. Ishii, Y. Suzuki, Y. Ikegami, Y. Kusunoki, Y. Takemoto, and K. Okada. 1987. Characterization of a mammalian mutant with a camptothecin resistant DNA topoisomerase I. Proc. Natl. Acad. Sci. USA. 84:5565-5569.
2. Bailly, C. 2003. Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs. Crit. Rev. Oncol. Hematol. 45:91-108.
3. Bailly, C, C. Carrasco, F. Hamy, H. Vezin, M. Prudhomme, A. Saleem, and E. Rubin. 1999. The camptothecin-resistant topoisomerase I mutant F361s is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles. Biochem. 38:8605-8611.
4. Benedetti, P., P. Fiorani, L. Capuani, and J. C. Wang. 1993. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res. 53:4343-4348.
5. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gusteren, A. Di Nola, and J. R. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Comput. Phys. 81:3684-3690.
6. Berendsen, H. J. C., D. van der Spool, and R. van Drunen. 1995. GROMACS: a message-passing parallel molecular dynamics implementation. Comp. Phys. Comm. 95:43-56.
7. Carey, J. F., S. J. Schultz, L. Sission, T. G. Fazzio, and J. J. Champoux. 2003. DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein. Proc. Natl. Acad. Sci. USA. 100:5640-5645.
8. Cheatham, T. E., J. L. Miller, T. Fox, T. A. Darden, and P. A. Kollman. 1995. Molecular dynamics simulation on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA and proteins. J. Am. Chem. Soc. 117:4193-4194.
9. Chen, Y., U. Narendra, L. E. Iype, M. M. Cox, and P. A. Rice. 2000. Crystal structure of a Flp recombinase-Holliday junction complex: assembly of an active oligomer by helix swapping. Mol. Cell. 6:885-897.
10. Chillemi, G., T. Castrignanò, and A. Desideri. 2001. Structure and hydration of the DNA-human topoisomerase I covalent complex. Biophys. J. 81:490-500.
11. Chillemi, G., P. Fiorani, P. Benedetti, and A. Desideri. 2003. Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Res. 31:1525-1535.
12. Chrencik, J. E., A. B. Burgin, Y. Pommier, L. Stewart, and M. R. Redinbo. 2003. Structural impact of the leukemia drug Ara-C on the covalent human topoisomerase I DNA complex. J. Biol. Chem. 278:12461-12466.
13. Chrencik, J. E., B. L. Staker, A. B. Burgin, P. Pourquier, Y. Pommier, L. Stewart, and M. R. Redinbo. 2004. Mechanisms of camptothecin resistance by human topoisomerase I mutations. J. Mol. Biol. 339:773-784.
14. Christensen, M. O., H. U. Barthelmes, F. Boege, and C. Mielke. 2003. Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro. Nucleic Acids Res. 31:7255-7263.
15. Cornell, W. D., P. Cieplak, C. I. Bayly, I. R. Gould, M. Kenneth, J. Merz, D. M. Ferguson, D. C. Spellmeyer, T. Fox, J. W. Caldwell, and P. A. Kolman. 1995. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:5179-5197.
16. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald: an N.log(n) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
17. Fertala, J., J. R. Vance, P. Pourquier, Y. Pommier, and M.-A. Bjomsti. 2000. Substitutions of Asn-726 in the Active Site of Yeast DNA Topoisomerase I Define Novel Mechanisms of Stabilizing the Covalent Enzyme-DNA Intermediate. J. Biol. Chem. 275:15246-15253.
18. Fiorani, P., J. F. Amatruda, A. Silvestri, R. H. Butler, M.-A. Bjornsti, and P. Benedetti. 1999. Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin Sensitivity. Mol. Pharmacol. 56:1105-1115.
19. Fiorani, P., A. Bruselles, M. Falconi, G. Chillemi, A. Desideri, and P. Benedetti. 2003. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I. J. Biol. Chem. 278:43268-43275.
20. Frohlich, R. F., F. F. Andersen, O. Westergaard, A. H. Andersen, and B. R. Knudsen. 2004. Regions within the N-terminal domain of human topoisomerase I exert important functions during strand rotation and DNA binding. J. Mol Biol. 336:93-103.
21. Giudice, E., and R. Lavery. 2002. Simulations of nucleic acids and their complexes. Acc. Chem. Res. 35:350-357.
22. Guo, F., D. N. Gopaul, and G. D. van Duyne. 1997. Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse. Nature. 389:40-46.
23. Harm, C., D. L. Evans, J. Fertala, P. Benedetti, M.-A. Bjornsti, and D. J. Hall. 1998. Increased camptothecin toxicity induced in mammalian cells expressing saccharomyces cerevisiae DNA topoisomerase I. J. Biol. Chem. 273:8425-8433.
24. Interthal, H., P. M. Quigley, W. G. J. Hol, and J. J. Champoux. 2004. The role of lysine 532 in the catalytic mechanism of human topoisomerase I. J. Biol. Chem. 279:2984-2992.
25. Ireton, G. C., L. Stewart, L. H. Parker, and J. J. Champoux. 2000. Expression of human topoisomerase I with a partial deletion of the linker region yields monomeric and dimeric enzymes that respond differently to camptothecin. J. Biol. Chem. 275:25820-25830.
26. Jorgensen, W. L., J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
27. Knab, A. M., J. Fertala, and M.-A. Bjornsti. 1993. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J. Biol. Chem. 268:22322-22330.
28. Knab, A. M., J. Fertala, and M.-A. Bjornsti. 1995. A Camptothecin- resistant DNA topoisomerase I mutant exhibits alteres sensitivities to other DNA topoisomerase poisons. J. Biol. Chem. 270:6141-6148.
29. Kwon, H. J., R. Tirumalai, A. Landy, and T. Ellenberger. 1997. Flexibility in DNA recombination: structure of the lambda integrase catalytic core. Science. 276:126-131.
30. Laco, G. S., J. R. Collins, B. T. Luke, H. Kroth, J. M. Sayer, D. M. Jerina, and Y. Pommier. 2002. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochem. 41:1428-1435.
31. Lesher, D. T., Y. Pommier, L. Stewart, and M. R. Redinbo. 2002. 8-oxoguanine rearranges the active site of human topoisomerase I. Proc. Natl. Acad. Sci. USA. 99:12102-12107.
32. Leteurtre, F., A. Fujimori, A. Tanizawa, A. Chhabra, A. Mazumder, G. Kohlhagen, H. Nakano, and Y. Pommier. 1994. Saintopin, a dual inhibitor of DNA topoisomerase I and II, as a probe for drug-enzyme interactions. J. Biol. Chem. 269:28702-28707.
33. Li, X. G., P. Haluska, Y.-H. Hsiang, A. K. Bharti, D. W. Kufe, L. F. Liu, and E. H. Rubin. 1997. Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis. Biochem. Pharmacol. 53:1019-1027.
34. Lisby, M., J. R. Olesen, C. Skouboe, B. O. Krogh, T. Straub, F. Boege, S. Velmurugan, P. M. Martensen, A. H. Andersen, M. Jayaram, O. Westergaard, and B. R. Knudsen. 2001. Residues within the N-terminal domain of human topoisomerase I play a direct role in relaxation. J. Bol. Chem. 276:20220-20227.
35. MacKerell, A. D., and L. Nilsson. 2001. Nucleic acid simulations. In Computational Biochemistry and Biophysics. O. Becker, A. D. MacKerell, B. Roux, and M. Watanabe, editors. Marcel Dekker, New York.
36. Mc Cammon, J. A., and S. C. Harvey. 1987. Dynamics of Proteins and Nucleic Acids. Cambridge University Press, London.
37. Pommier, Y., P. Pourquier, Y. Fan, and D. Strumberg. 1998. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta. 1400:83-106.
38. Pommier, Y., P. Pourquier, Y. Urasaki, J. Wu, and G. S. Laco. 1999. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resist. Updat. 2:307-318.
39. Pommier, Y., C. Redon, V. A. Rao, J. A. Seiler, O. Sordet, H. Takemura, S. Antony, L. H. Meng, Z. Y. Liao, G. Kohlhagen, H. L. Zhang, and K. W. Kohn. 2003. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat. Res. 532:173-203.
40. Reddy, S. Y., S. Obika, and T. C. Bruice. 2003. Conformations and dynamics of Ets-1 ETS domain-DNA complexes. Proc. Natl. Acad. Sci. USA. 100:15475-15480.
41. Redinbo, M. R., J. J. Champoux, and W. G. J. Hol. 2000. Novel Insight into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. Biochemistry. 39:6832-6840.
42. Redinbo, M. R., L. Stewart, J. J. Champoux, and W. G. J. Hol. 1999. Structural flexibility in human topoisomerase I revealed in multiple nonisomorphous crystal structures. J. Mol. Biol. 292:685-696.
43. Redinbo, M. R., L. Stewart, P. Kuhn, J. J. Champoux, and W. G. J. Hol. 1998. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science. 279:1504-1513.
44. Rubin, E., P. Pantazis, A. Bharti, D. Toppmeyer, B. Giovannella, and D. Kufe. 1994. Identification of a mutant topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J. Biol. Chem. 269:2433-2439.
45. Ryckaert, J.-P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
46. Saleem, A., N. Ibrahim, M. Patel, X. G. Li, E. Gupta, J. Mendoza, P. Pantazis, and E. H. Rubin. 1997. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning. Cancer Res. 57:5100-5106.
47. Staker, B. L., K. Hjerrild, M. D. Feese, C. A. Behnke, A. B. Burgin, and L. Stewart. 2002. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. USA. 99:15387-15392.
48. Stewart, L., G. Ireton, and J. Champoux. 1997. Reconstitution of human topoisomerase I by fragment complementation. J. Mol. Biol. 269:355-372.
49. Stewart, L., G. Ireton, and J. Champoux. 1999. A Functional linker in human topoisomerase I is required for maximum sensitivity to camptothecin in a DNA relaxation assay. J. Biol. Chem. 274:32950-32960.
50. Stewart, L., M. R. Redinbo, X. Qiu, W. G. J. Hol, and J. J. Champoux. 1998. A model for the mechanism of human topoisomerase I. Science. 279:1534-1541.
51. Subramanya, H. S., L. K. Arciszewska, R. A. Baker, L. E. Bird, D. J. Sherratt, and D. B. Wigley. 1997. Crystal structure of the site-specific recombinase, XerD. EMBO J. 16:5178-5187.
52. Tamura, H., C. Kohchi, R. Yamada, T. Ikeda, O. Koiwai, E. Patterson, J. D. Keene, K. Okada, E. Kjeldsen, K. Nishikawa. 1991. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites. Nucleic Acids Res. 19:69-75.
53. Tsui, V., I. Radhakrishnan, P. E. Wright, and D. A. Case. 2000. NMR and molecular dynamics studies of the hydration of a zinc finger-DNA complex. J. Mol. Biol. 302:1101-1117.
54. Urasaki, Y., G. S. Laco, P. Pourquier, Y. Takebayashi, G. Kohlhagen, C. Gioffre, H. Zhang, D. Chatterjee, P. Pantazis, and Y. Pommier. 2001. Characterization of a novel topoisomerase I mutation from a camptothecin- resistant human prostate cancer cell line. Cancer Res. 61:1964-1969.
55. Van der Spoel, D., and H. J. C. Berendsen. 1997. Molecular dynamics simulations of leu-enkephalin in water and DMSO. Biophys. J. 72:2032-2041.
56. Woo, M. H., C. Losasso, H. Guo, L. Pattarello, P. Benedetti, and M. A. Bjomsti. 2003. Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality. Proc. Natl. Acad. Sci. USA. 100:13767-13772.